NHS England to offer breakthrough treatment for sickle cell disease

Thousands of patients in England are to benefit from the first treatment for sickle cell disease in two decades, the NHS has announced.

Crizanlizumab, a “revolutionary” life-changing drug treatment, is delivered by a transfusion drip and works by binding to a protein in the blood cells to prevent the restriction of blood and oxygen supply.

The therapy, the first to become available for the disease in 20 years, will help at least 5,000 people over the next three years, officials said.

Sickle cell disease – particularly common in people with an African or Caribbean background – is a serious and lifelong health condition. It can cause severe pain and organ failure, often requiring hospital admissions.

Current treatments to prevent sickle cell crises include a tablet called hydroxycarbamide and regular blood transfusions, but these are not always effective for people with severe forms of the disease.

“This is a historic moment for people with sickle cell disease who will be given their first new treatment in over two decades,” said Amanda Pritchard, chief executive of NHS England. “This revolutionary treatment will help to save lives, allow patients to have a better quality of life and reduce trips to A&E by almost half.”

People aged over 16 who suffer from multiple sickle cell crises every year will be eligible for the treatment. The disease is characterised by the production of unusually shaped red blood cells, which can cause serious health issues across the body, sending organs into crisis and causing extreme pain.

Toks Odesanmi, a sickle cell patient at Cambridge University hospitals trust, welcomed the arrival of the treatment and said it gave her new hope.

“Sickle cell disease has defined me, defined my body and made a big dent to my dreams,” said Odesanmi, 47, a finance specialist from Colchester. “No matter how hard I fight, it continues to defeat me. A new treatment brings hope and might make dreaming possible again.”

Sickle Cell Society chair Kye Gbangbola said: “A new treatment brings new hope for people living with sickle cell disorder, the world’s most common genetic blood condition. SCD is a medical emergency, it causes excruciating pain. This new treatment will reduce the number of agonising pain episodes we have to endure.

“The hope is improved quality of life for many living with the condition and their families.”

Source: NHS England to offer breakthrough treatment for sickle cell disease

*This is a free press release. Upgraded press releases are ad-free!

Waymo self driving cars clog up San Francisco cul-de-sac

Residents of a cul-de-sac in San Francisco say their neighbourhood is regularly playing host to a gathering of Waymo self driving cars and they don’t know why.According to local news station KPIX, the self driving cars have been driving up and down the “dead-end” street at all hours of the day “for weeks”, with no…

Read Press Release

SB 9 Rezoning Could Impact High Fire Risk Areas: Firefighter

With a significant number of destructive wildfires affecting California in recent years, some residents are questioning the potential effect of new legislation aimed at increasing density in the state’s single-family zoned neighborhoods. Senate Bill 9 (SB 9), recently signed by the governor, appears to exclude very high fire hazard severity zones. However, Livable California claims that SB…

Read Press Release

Bank of Japan confirms central bank digital currency trial

CBDC trial has commenced by the Bank of JapanThe trial includes three stages, among which two phases are for Proof-of-ConceptThe bank revealed that the first phase will last for a year until March 2022CBDC or central bank digital currency has become something that almost every central bank is looking into. People’s Bank of China (PBoC)…

Read Press Release

NHS England to offer breakthrough treatment for sickle cell disease - Click To Share

Share on facebook
Share on twitter
Share on reddit
Share on linkedin
Share on email
Share on whatsapp